Analyst notes from Wedbush on losing patience with Elon Musk, Goldman Sachs on downgrading U.S. GDP, and Convera on equities.

Bicara Therapeutics’ (NASDAQ:BCAX – Get Free Report) lock-up period will expire on Wednesday, March 12th. Bicara Therapeutics had issued 17,500,000 shares in its initial public offering on September ...

Tesla’s brand is going through a Bud Light moment, Southwest to charge for luggage as airlines slash guidance, and more news ...

Donald Trump has dropped his plans to double the tariffs on Canadian steel and aluminum. Newsweek's live blog is closed.

Despite the recent sell-off in tech stocks, analysts at Wedbush believe that this downturn is temporary and that AI leaders ...

As previously reported, Wedbush analyst Alicia Reese upgraded Logitech (LOGI) to Outperform from Neutral with a price target of $125, up from ...

Vermont Business Magazine Yesterday in Montpelier, the Vermont Natural Resources Council (VNRC), the Preservation Trust of ...

Despite the recent rash of tech stock sell-offs, the analysts at Wedbush believe this is a short-term phenomenon, and the ...

Wedbush Securities is making a big statement ... which he believes could spur massive growth. A key highlight is the rumored sub-$35,000 electric vehicle, which Ives expects to launch before ...

Nvidia ( NASDAQ: NVDA) is set to host its annual GTC conference next week and with tech stocks under pressure from tariffs, concerns of a recession and negative sentiment, Wedbush Securities believes ...

Palantir Technologies Inc. Senior Counselor Samantha Clark has urged the Pentagon to embrace commercial software solutions or ...